wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q36912766-6339319D-3AFB-4D70-809F-265A093646DF
Q36912766-6339319D-3AFB-4D70-809F-265A093646DF
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36912766-6339319D-3AFB-4D70-809F-265A093646DF
Overactive bladder - 18 years - Part II
P2860
Q36912766-6339319D-3AFB-4D70-809F-265A093646DF
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36912766-6339319D-3AFB-4D70-809F-265A093646DF
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
a60a47464a082fcd9371d09e2bf6f973c8e8804f
P2860
Randomized, double-blind placebo- and tolterodine-controlled trial of the once-daily antimuscarinic agent solifenacin in patients with symptomatic overactive bladder.